Empower India Limited Board Approves MD and CFO Resignation Due to Medical Reasons
Empower India Limited announced the resignation of Managing Director and CFO Rajgopalan Iyengar effective April 08, 2026, citing medical reasons requiring immediate attention. The Board of Directors formally approved the resignation during a meeting held on April 09, 2026, ensuring full compliance with SEBI regulatory requirements and proper disclosure procedures.

*this image is generated using AI for illustrative purposes only.
Empower India Limited has announced a significant leadership change with the resignation of its Managing Director and Chief Financial Officer, Mr. Rajgopalan Iyengar, effective from April 08, 2026. The development was disclosed through a regulatory filing under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Board Meeting Outcome
The company's Board of Directors convened on April 09, 2026, from 04:30 PM to 05:00 PM at the registered office to formally address and approve Mr. Iyengar's resignation. The meeting was held in compliance with regulatory requirements to ensure proper disclosure of material changes in key management personnel.
Resignation Details
Mr. Rajgopalan Iyengar (DIN: 00016496) submitted his resignation letter on April 08, 2026, citing medical reasons that require his immediate and complete attention. In his resignation letter, he expressed that this was a difficult decision made with deep responsibility toward his health and well-being.
| Parameter: | Details |
|---|---|
| Effective Date: | April 08, 2026 |
| Reason: | Medical reasons |
| Position: | Managing Director and CFO |
| DIN: | 00016496 |
| Other Directorships: | NIL |
| Meeting Time: | 04:30 PM to 05:00 PM |
| Script Code: | 504351 |
Regulatory Compliance
The company has fulfilled all disclosure requirements under SEBI regulations, providing comprehensive details as mandated. The filing was made pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations and SEBI Master Circular dated January 30, 2026. Key compliance aspects include:
- Submission of detailed resignation letter with reasons
- Confirmation of no other material reasons beyond medical grounds
- Declaration of no directorships in other listed entities
- Proper board resolution and approval process
Leadership Transition
Mr. Iyengar acknowledged the inconvenience his sudden departure may cause to the organization while expressing gratitude for the trust and support extended during his tenure. He described his service as an honor and highlighted his contribution to the organization's growth and success.
The resignation letter confirms that there are no other reasons beyond the medical circumstances mentioned, providing clarity on the nature of his departure. The company has not yet announced interim arrangements or succession plans for the dual role of Managing Director and Chief Financial Officer. Director Satyawan Jankar (DIN: 10711274) signed the regulatory filing on behalf of the company.
Who will Empower India appoint as interim Managing Director and CFO to fill the leadership vacuum?
How might this sudden dual-role departure impact Empower India's upcoming financial reporting and strategic initiatives?
What succession planning measures does Empower India have in place for such critical leadership transitions?





























